|
Volumn 39, Issue 2, 2016, Pages 231-241
|
A phase 2, randomized, dose-finding study of the novel once-weekly human GLP-1 analog, semaglutide, compared with placebo and open-label liraglutide in patients with type 2 diabetes
|
Author keywords
[No Author keywords available]
|
Indexed keywords
HEMOGLOBIN A1C;
LIRAGLUTIDE;
PLACEBO;
SEMAGLUTIDE;
ANTIDIABETIC AGENT;
GLUCAGON LIKE PEPTIDE;
GLUCOSE BLOOD LEVEL;
GLYCOSYLATED HEMOGLOBIN;
ADULT;
AGED;
ANOREXIA;
ARTICLE;
ASTHENIA;
CONNECTIVE TISSUE DISEASE;
CONSTIPATION;
CONTROLLED STUDY;
DECREASED APPETITE;
DIABETIC RETINOPATHY;
DIARRHEA;
DISEASE SEVERITY;
DIZZINESS;
DOSAGE SCHEDULE COMPARISON;
DOSE RESPONSE;
DOUBLE BLIND PROCEDURE;
DRUG DOSE COMPARISON;
DRUG DOSE ESCALATION;
DRUG DOSE INCREASE;
DRUG RESPONSE;
DRUG SAFETY;
DRUG TOLERABILITY;
DRUG WITHDRAWAL;
DYSPEPSIA;
FATIGUE;
FEMALE;
GLYCEMIC CONTROL;
HEADACHE;
HEART DISEASE;
HEMATOLOGIC DISEASE;
HEMOGLOBIN BLOOD LEVEL;
HUMAN;
HYPERTENSION;
HYPOGLYCEMIA;
INJECTION SITE REACTION;
LETHARGY;
LYMPHATIC SYSTEM DISEASE;
MAJOR CLINICAL STUDY;
MALE;
MEDIASTINUM DISEASE;
MENTAL DISEASE;
MUSCULOSKELETAL DISEASE;
NAUSEA;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PARALLEL DESIGN;
PHASE 2 CLINICAL TRIAL;
RANDOMIZED CONTROLLED TRIAL;
RESPIRATORY TRACT DISEASE;
RHINOPHARYNGITIS;
SKIN DISEASE;
THORAX DISEASE;
URINARY TRACT INFECTION;
VOMITING;
WEIGHT CHANGE;
ANALOGS AND DERIVATIVES;
BODY WEIGHT;
CHEMICALLY INDUCED;
CLINICAL TRIAL;
DIABETES MELLITUS, TYPE 2;
DRUG ADMINISTRATION;
DRUG EFFECTS;
GLUCOSE BLOOD LEVEL;
MIDDLE AGED;
SUBCUTANEOUS DRUG ADMINISTRATION;
TREATMENT OUTCOME;
ADULT;
BLOOD GLUCOSE;
BODY WEIGHT;
DIABETES MELLITUS, TYPE 2;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DOUBLE-BLIND METHOD;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
GLUCAGON-LIKE PEPTIDES;
HEMOGLOBIN A, GLYCOSYLATED;
HUMANS;
HYPOGLYCEMIA;
HYPOGLYCEMIC AGENTS;
INJECTIONS, SUBCUTANEOUS;
LIRAGLUTIDE;
MALE;
MIDDLE AGED;
NAUSEA;
TREATMENT OUTCOME;
VOMITING;
|
EID: 84962052845
PISSN: 01495992
EISSN: 19355548
Source Type: Journal
DOI: 10.2337/dc15-0165 Document Type: Article |
Times cited : (170)
|
References (17)
|